Primary Care Clinical Pathway for Acute Asthma
Contact provider with concerning chief complaint
- Nursing: Obtain VS: HR, RR, Temperature, Pulse Oximetry
- Provider: Visual/Respiratory Assessment
- Determine Level of Severity of Asthma Exacerbation
- Notify provider if severe work of breathing, SpO2 < 95%
- Place all children in exam room, visibly monitored by staff
- Albuterol
- Consider oral steroids
- Albuterol, 4 puffs or albuterol + ipratropium, based on clinical situation
- Strongly consider oral steroids
- Supplemental oxygen for persistent SpO2 < 95%
- Activate 911
- Provider/nursing at bedside
- Continuous HR, pulse oximetry
- Frequent respiratory assessments
- Reassess 15–30 mins
- Discharge if mild
- Albuterol + ipratropium
- Oral steroids
- Supplemental oxygen for persistent SpO2 < 95%
- Severe distress
- Impending respiratory failure
- Albuterol + ipratropium
- Code cart to room
- Consider EpiPen
- Oral Steroids
- Supplemental oxygen for persistent SpO2 < 95%
Reassess 20–30 min
Repeat albuterol dose ×2 as clinically indicated
Repeat albuterol dose ×2 as clinically indicated
Repeat albuterol dose ×2 as clinically indicated
Mild
Moderate/Severe
| Medication | Weight, Kg | Dose |
|---|---|---|
| Albuterol Weight-based dosing |
> 5 |
|
| Ipratropium Weight-based dosing |
5–10 |
|
| > 10 |
|
|
| Dexamethasone Preferred oral steroid Mild-moderate flare, repeat in 24–48 hrs, crush tablet with cherry syrup, juice, or yogurt |
5–8 | 4 mg |
| > 8–12 | 6 mg | |
| > 12 | 8 mg | |
| Prednisone |
|
|
| Epinephrine (IM) | 5–24 | EpiPen Jr: 0.15 mg/0.3 mL |
| ≥ 25 | EpiPen: 0.3 mg/0.3 mL |
Evidence
- 2020 Focused Updates to the Asthma Management Guidelines: Clinician's Guide
- Follow-Up Care After an ED Visit
- 2024 Gina Main Report
- 2025 Gina Summary Guide
